Guardian Bio
Dendritic cell-based platform for cancer therapy Status: Active. Batch: YC Summer 2022. HQ: Boston, MA, USA. Industry: Healthcare. http://www.guardian-bio.com
Details
- city
- Boston
- cohort year
- 2022
- country
- United States
- exited
- false
- industry
- healthcare
- one liner
- Dendritic cell-based platform for cancer therapy
- status
- active
- team size
- 2
accelerator → invested in1
participated in → cohort1